Pharmaceutical Companies, Intellectual Property And Research Paper

Length: 8 pages Sources: 5 Subject: Medicine Type: Research Paper Paper: #4041602 Related Topics: Intellectual Property, Property Rights, Merck, Aids
Excerpt from Research Paper :

As a result, this protection was removed to increase the supply and ensure that the public has access to affordable drugs. ("Pharmaceutical Companies," n.d., pp. 97-99)

Some of the negative implications of this decision are that there could be large amounts of generic drugs produced. This is because the various protections were removed to the point, that a number of players could begin manufacturing the medication. Over the course of time, this could destroy any kind of financial incentive in these areas. Once this occurs, it means that any kind of profit motives for these firms to sell drugs in these areas will decrease. This is when the available supply could decline, because there is too much competition. ("Pharmaceutical Companies," n.d., pp. 97-99)

At the same time, the quality of products could be inferior. This is because many firms will have select procedures in place to ensure that everyone is receiving the right dosage. The problem is that some companies could reduce this amount. Once this takes place, it means that these drugs will not be as effective in helping to treat those who are suffering from HIV / AIDS. Once this occurs, is when larger segments of the poor and middle class could begin to see higher mortality rates from the disease. ("Pharmaceutical Companies," n.d., pp. 97-99)

The way that this could impact other industries is to remove protections they enjoy for particular products. Where, their underling costs will increase for related materials such as bottles and plastic bags. This is because the medication is being distributed to larger segments of the population. Once this occurs, it means that various industries could be dealing with possible inflation issues down the road. This is the point that other industries will have trouble keeping up with these rising costs (which they are passing onto consumers). ("Pharmaceutical Companies," n.d., pp. 97-99)

Given the initiatives announced by global development and aid organizations and among pharmaceutical companies themselves, was it necessary to relax IPR rules in order to ensure that adequate supplies of AIDs medications would be available for distribution in the developing world?

Yes, the reason why the various rules had to be relaxed was to ensure that everyone had access to these drugs when they need them. If they kept the current...


This would have caused uneven amounts of economic growth, which would have an adverse impact on any kind of economic development. This is because large segments of the population have higher mortality rates. Over the course of time, this will create a situation where there will be issues of declining productivity and a loss in the wealth of these regions. ("Pharmaceutical Companies," n.d., pp. 94-103)

As a result, once there was some kind change in regulations is when drug manufactures were able to supply developing countries with larger quantities. This is the point they increased their market share in these areas. While at the same time, they addressed the lingering public health issues that were facing many of these nations. Once this occurred, is when there would be an increase in the total amounts of supplies that were available in these regions. This is when the mortality rates associated with the disease began to stabilize and then decrease. ("Pharmaceutical Companies," n.d., pp. 94-103)

What role do MNCs have in providing funding or other assistance to international organizations such as the Global Fund?

The way that MNC's are providing funding to international organizations is to establish for profit entities that will distribute HIV / AIDS drugs to these areas. The way that this works, is these various nonprofits, corporations and governments can make contributions to this fund. They will provide assistance to developing nations in offering the public these drugs for lower costs or free. Once this occurs, it means that they are addressing the epidemic by providing the public with a way to ensure that these areas receive the medication they need. This is when the manufactures will be able to maintain their profit margins. While at the same time, it is providing developing nations with a vital supply of drugs for large segments of the population. ("Pharmaceutical Companies," n.d., pp. 94-103)

Clearly, the HIV / AIDS crisis is creating shifts in the way that drug companies are looking at issues such as patent protections. This is because the standard rules of the past, are offering them with a way of maximizing their profits. However, it is also effectively helping select segments of these populations. Once this occurs, is when the mortality rate in these areas will increase exponentially. This is the point that economic growth in these regions could reverse. To deal with these lingering issues, the regulations on patent protections were loosened to increase the available supply to consumers. Over the course of time, this providing these areas with a large amount of drugs that are available to the general public. At the same time, it helped to keep the costs of the medication as low as possible. This is when most people could afford the treatment options that were available. Once this took place, it meant that total number of deaths began to decline consistently. As a result, the net impact of these efforts is that they helped to save millions of lives around the world.


Global Report. (2009). UNAIDS. Retrieved from:

Pharmaceutical Companies. (n.d.)., 94 -- 103.

Hunter, S. (2003). Black Death. New York, NY: McMillian

Poku, N. (2005). AIDS in Africa. Cambridge: Poulty.

Shinn, D. (2008). African Migration and the Brain Drain. Institute for African Studies. Retrieved…

Sources Used in Documents:


Global Report. (2009). UNAIDS. Retrieved from:

Pharmaceutical Companies. (n.d.)., 94 -- 103.

Hunter, S. (2003). Black Death. New York, NY: McMillian

Poku, N. (2005). AIDS in Africa. Cambridge: Poulty.

Cite this Document:

"Pharmaceutical Companies Intellectual Property And" (2011, November 19) Retrieved June 19, 2021, from

"Pharmaceutical Companies Intellectual Property And" 19 November 2011. Web.19 June. 2021. <>

"Pharmaceutical Companies Intellectual Property And", 19 November 2011, Accessed.19 June. 2021,

Related Documents
Pharmaceutical Companies Intellectual Property and the Global AIDS...
Words: 2358 Length: 8 Pages Topic: Disease Paper #: 91128704

Pharmaceutical Companies, Intellectual Property, and the Global AIDS Epidemic For this case study, six questions had been asked. The first one is: Should pharmaceutical companies distribute drugs at low cost in third world countries? What are the pros and cons of such an approach? The second one is: What are the principal arguments of pharma companies who oppose making exception to IPR laws for developing countries? What are the arguments by

Intellectual Property Rights Several Countries
Words: 1430 Length: 3 Pages Topic: Economics - Economists Paper #: 8614412

However, the rights have some confinements incorporating the limitations and other considerations of issues like their contradiction with the fundamental rights and the codified provisions in force. The legal issues involving intellectual property rights have two dimensions. Firstly, those that provide exclusive rights only in the sphere of copying / reproduction of the item or act safeguarded and secondly, those which provide a right to deter others from doing

Pharmaceutical Company: Lions Gate Chief
Words: 1030 Length: 4 Pages Topic: Business Paper #: 73792151

Managed a team of 50 people that includes 10 direct reports. Grew Wal-mart drugs portfolio profit by $14 Million (+26%) through driving volume growth and reconfiguration of packaging offerings that drove significant cost savings. Responsibilities and duties: Maintains full accountability for profit and loss and delivering volume and profit objectives. Spearheads both strategic and tactical initiatives that leads to growth of Liongate's new product. Reshapes marketing organization through effective recruiting,

Legal and Ethical Considerations in Marketing Product Safety and...
Words: 3091 Length: 10 Pages Topic: Business - Advertising Paper #: 88383960

Marketing, Product Safety, and Intellectual Property Ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety Various organizations often find themselves in the wrong side of the law when undertaking their various business practices relating to marketing and advertisement. It is the desire of every company to have its product known to as many consumers as possible. This often drives them to employ diverse marketing and advertisement

Ethical and Legal Considerations Intellectual Property and Product...
Words: 1846 Length: 5 Pages Topic: Business Paper #: 60943371

Business operations are deemed viable of they succeed in establishing conditions that guarantee safety for its product consumers. Specified standards are applied by business entities to attain such viability. These considerations are critical in product safety, intellectual property, and marketing in general. If a company or business entity violates any of the aspects mentioned, it stands a high risk being caught in a web of ethical and legal complications that

Marketing Product Safety, and Intellectual Property Legal
Words: 2675 Length: 9 Pages Topic: Business - Ethics Paper #: 46206825

Marketing Product Safety, And Intellectual Property Legal and Ethical Considerations in Marketing, Product Safety, and Intellectual Ethics and legal issues refer to the morals and principles that govern the behavior and conduct of individuals or organizations. These legal principles and ethics serve to guide and offer directions on how to act or respond when faced with moral dilemmas. Marketing, advertising and product safety are areas of importance to everyone in the community.